Overexpression of CCK Neuropeptide in brain is linked to ZBTB20 mutations: potential diagnostic relevance in glioblastoma

Abstract Glioblastoma (GBM), the most malignant central nervous system cancer, has a median survival rate of 14–16 months. GBM patients have a poor prognosis despite rigorous multi-modal treatments like surgical resection, chemotherapy, and radiation. A systematic bioinformatics analysis of GXA gene...

詳細記述

書誌詳細

出版年:	BMC Medical Genomics
主要な著者:	Tikam Chand Dakal, Narendra Kumar Sharma, Vikas Yadav, Abhishek Kumar, Peng Chen, Ingo Schmidt-Wolf, Jarek Maciaczyk, Amit Sharma
フォーマット:	論文
言語:	英語
出版事項:	BMC 2025-10-01
主題:	Glioblastoma CCK gene expression IDH1 mutations Brain cortex Brain frontal cortex
オンライン･アクセス:	https://doi.org/10.1186/s12920-025-02218-0